Drug Detail

Information about Imatinib + BYL719

Generic Name
Imatinib + BYL719
IND
Brand Name (US)
Manufacturer
Novartis
Drug Type
Delivery
Oral
Approval Status
Indications
Overall Strategy
KIT Protein Based + Oncogenic Signal Path Based
Strategy
Block KIT + Block KIT Signal Path
Drug Category
KIT/PDGFRA inhibitor + PI3K inhibitor